| Dr Robert Charles Blackwood, MD | |
|
1201 Lake James Dr, Suite 200, Virginia Beach, VA 23464-6780 | |
| (757) 523-0022 | |
| (757) 523-5018 |
| Full Name | Dr Robert Charles Blackwood |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 1201 Lake James Dr, Virginia Beach, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407841968 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0101051005 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Home Care Services-virginia Beach | Chesapeake, VA | Home health agency |
| Sentara Leigh Hospital | Norfolk, VA | Hospital |
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Chesapeake Regional Medical Center | Chesapeake, VA | Hospital |
| Sentara Princess Anne Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Medical Group Llc | 4385682061 | 1176 |
News Archive
CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-generation DNA sequencing, announced $6M in Series B funding.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced it has received approval from the Food and Drug Administration (FDA) for its Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices). BIOTRONIK follows this milestone with the launch of its next generation unique technology platform Ilesto DX.
Worldwide, obesity is becoming more prevalent. According to The World Health Organization, worldwide obesity has nearly doubled since 1980, and in 2008 25% of adults aged 20 and over were overweight, and another 11% were obese. Obesity has been identified as a major source of unsustainable health costs and numerous adverse outcomes, including morbidity and mortality due to hypertension, type 2 diabetes, cardiovascular diseases and certain types of cancer.
› Verified 4 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20140603000011 |
News Archive
CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-generation DNA sequencing, announced $6M in Series B funding.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced it has received approval from the Food and Drug Administration (FDA) for its Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices). BIOTRONIK follows this milestone with the launch of its next generation unique technology platform Ilesto DX.
Worldwide, obesity is becoming more prevalent. According to The World Health Organization, worldwide obesity has nearly doubled since 1980, and in 2008 25% of adults aged 20 and over were overweight, and another 11% were obese. Obesity has been identified as a major source of unsustainable health costs and numerous adverse outcomes, including morbidity and mortality due to hypertension, type 2 diabetes, cardiovascular diseases and certain types of cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Charles Blackwood, MD 1201 Lake James Dr, Suite 200, Virginia Beach, VA 23464-6780 Ph: (757) 523-0022 | Dr Robert Charles Blackwood, MD 1201 Lake James Dr, Suite 200, Virginia Beach, VA 23464-6780 Ph: (757) 523-0022 |
News Archive
CosmosID, the leading genomic big data company focused on microbiome research, outbreak investigations, and infectious disease diagnostics, using next-generation DNA sequencing, announced $6M in Series B funding.
Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced positive results from the Phase 1 portion of its Phase 1/1b study of defactinib (VS-6063) in combination with paclitaxel in patients with ovarian cancer that were presented at the 2013 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston.
BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced it has received approval from the Food and Drug Administration (FDA) for its Ilesto family of implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillators (ICD/CRT-D devices). BIOTRONIK follows this milestone with the launch of its next generation unique technology platform Ilesto DX.
Worldwide, obesity is becoming more prevalent. According to The World Health Organization, worldwide obesity has nearly doubled since 1980, and in 2008 25% of adults aged 20 and over were overweight, and another 11% were obese. Obesity has been identified as a major source of unsustainable health costs and numerous adverse outcomes, including morbidity and mortality due to hypertension, type 2 diabetes, cardiovascular diseases and certain types of cancer.
› Verified 4 days ago
Dale-marie Nekeisha Mckie, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 5516 Virginia Beach Blvd, Virginia Beach, VA 23462 Phone: 757-473-3969 | |
Dr. George Bullard Jr., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1120 First Colonial Rd, Suite 100, Virginia Beach, VA 23454 Phone: 757-481-2333 Fax: 757-481-1037 | |
Dr. William M Hurst, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4005 Richardson Rd, Virginia Beach, VA 23455 Phone: 757-462-7403 Fax: 757-462-4292 | |
Dr. Julian Lee Greer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 332 Newtown Rd, Virginia Beach, VA 23462 Phone: 757-473-8400 | |
Dr. Michael George Charles, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3745 Holland Rd Ste 200, Virginia Beach, VA 23452 Phone: 757-395-1700 Fax: 757-507-9004 | |
Dr. Robin N Anderson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2017 Pleasure House Rd, Virginia Beach, VA 23455 Phone: 757-318-6900 Fax: 757-318-6901 | |
Biswa Bhattacharyya, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2088 S Independence Blvd Ste 103, Virginia Beach, VA 23453 Phone: 757-275-9331 Fax: 757-416-7656 |